Bajaj Healthcare launches Favipiravir tablets to treat mild-to-moderate Covid cases

The firm has successfully developed the active pharmaceutical ingredient (API) and the formulation for Favipiravir through its own in-house R&D team.The drug will be available as a prescription-based medication, with recommended doses